Related Experiment Video
Updated: Jul 21, 2025
08:50
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
772
Platelet-derived extracellular vesicles for drug delivery
1Laboratory for Biomaterial and ImmunoEngineering, Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, Jiangsu 215123, China. cwang@suda.edu.cn.
Biomaterials Science
|July 25, 2023
Summary
Platelet-derived extracellular vesicles (PEVs) show promise as targeted drug delivery systems. This review explores their biological roles and potential for delivering therapeutics to inflammatory sites.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Nanotechnology
Background:
- Platelet-derived extracellular vesicles (PEVs) are released from platelets, crucial for hemostasis and thrombosis.
- PEVs are implicated in physiological and pathological processes like inflammation, angiogenesis, and cancer.
- Extracellular vesicles (EVs) are increasingly recognized for their biological significance.
Purpose of the Study:
- To review the biological functions of PEVs.
- To summarize recent advancements in using PEVs for targeted drug delivery.
- To provide an outlook on the future development of PEV-based drug delivery platforms.
Main Methods:
- Literature review of studies on PEV biology and drug delivery applications.
- Analysis of PEV targeting mechanisms (passive and active).
- Synthesis of current research on PEV therapeutic potential.
Main Results:
- PEVs possess diverse biological functions relevant to disease.
- PEVs can be engineered or utilized for targeted delivery of therapeutics.
- PEVs demonstrate potential for targeting inflammatory sites.
Conclusions:
- PEVs represent a promising platform for targeted drug delivery.
- Further research is needed to optimize PEV-based therapeutic strategies.
- PEV technology holds significant potential for advancing nanomedicine.
